Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;10(3):247-248.
doi: 10.1002/ueg2.12215. Epub 2022 Mar 1.

Ulcerative colitis, a transmural disease requiring an accurate IUS assessment in the current treat-to-target era

Michael Dolinger  1 , Bram Verstockt  2   3
Affiliations
Editorial

Ulcerative colitis, a transmural disease requiring an accurate IUS assessment in the current treat-to-target era

Michael Dolinger et al. United European Gastroenterol J. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Michael Dolinger reports consultancy fees from Neurologica Corp.

Bram Verstockt reports research support from Pfizer; speaker's fees from Abbvie, Biogen, Bristol Myers Squibb, Chiesi, Falk, Ferring, Galapagos, Janssen, MondayNightIBD, MSD, Pfizer, R‐Biopharm, Takeda, Truvion and Viatris; consultancy fees from Alimentiv, Applied Strategic, Atheneum, Bristol Myers Squibb, Galapagos, Guidepont, Ipsos, Janssen, Progenity, Sandoz, Sosei Heptares and Takeda.

Comment on

References

    1. Ungaro R, Mehandru S, Allen PB, Peyrin‐Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756–70. - PMC - PubMed
    1. Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE‐II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat‐to‐target strategies in IBD. Gastroenterology. 2021;160:1570–83. - PubMed
    1. Allocca M, Dell’Avalle C, Craviotto V, Furfaro F, Zilli A, D’Amic F, et al. Predictive value of Milan Ultrasound Criteria in ulcerative colitis: a prospective observational cohort study. United Eur Gastroenterol J. 2022. - PMC - PubMed
    1. Allocca M, Fiorino G, Bonovas S, Furfaro F, Gilardi D, Argollo M, et al. Accuracy of Humanitas ultrasound criteria in assessing disease activity and severity in ulcerative colitis: a prospective study. J Crohns Colitis. 2018;12:1385–91. - PMC - PubMed
    1. Allocca M, Filippi E, Costantino A, Bonovas S, Fiorino G, Furfaro F, et al. Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation. United Eur Gastroenterol J. 2021;9:438–42. - PMC - PubMed

MeSH terms